Gilli Erez

438 total citations
9 papers, 320 citations indexed

About

Gilli Erez is a scholar working on Surgery, Rheumatology and Molecular Biology. According to data from OpenAlex, Gilli Erez has authored 9 papers receiving a total of 320 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Surgery, 3 papers in Rheumatology and 2 papers in Molecular Biology. Recurrent topics in Gilli Erez's work include Glycogen Storage Diseases and Myoclonus (2 papers), Cholesterol and Lipid Metabolism (2 papers) and Lipoproteins and Cardiovascular Health (2 papers). Gilli Erez is often cited by papers focused on Glycogen Storage Diseases and Myoclonus (2 papers), Cholesterol and Lipid Metabolism (2 papers) and Lipoproteins and Cardiovascular Health (2 papers). Gilli Erez collaborates with scholars based in Israel, Netherlands and United States. Gilli Erez's co-authors include Lucy Selman, Fliss EM Murtagh, Orly Elpeleg, Ann Saada, Avraham Shaag, Frédéric M. Vaz, Eran Leitersdorf, Gideon Eshel, Riekelt H. Houtkooper and Laurence Hubert and has published in prestigious journals such as The American Journal of Human Genetics, International Journal of Obesity and Atherosclerosis.

In The Last Decade

Gilli Erez

9 papers receiving 316 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gilli Erez Israel 7 120 107 73 73 58 9 320
Xian-Qiang Ni China 11 155 1.3× 57 0.5× 56 0.8× 31 0.4× 15 0.3× 13 333
Ran Hee Choi United States 6 207 1.7× 42 0.4× 44 0.6× 32 0.4× 94 1.6× 14 315
Beverley A. Millward United Kingdom 10 98 0.8× 42 0.4× 71 1.0× 17 0.2× 53 0.9× 14 340
A. Hunter Canada 7 122 1.0× 38 0.4× 21 0.3× 43 0.6× 78 1.3× 12 342
J. Mitchell United States 8 123 1.0× 61 0.6× 16 0.2× 48 0.7× 50 0.9× 28 300
Alton G. Sutter United States 9 187 1.6× 78 0.7× 46 0.6× 32 0.4× 59 1.0× 13 333
Kamal Chokkalingam United Kingdom 11 110 0.9× 40 0.4× 107 1.5× 30 0.4× 198 3.4× 14 343
Makoto Usami Japan 8 158 1.3× 82 0.8× 31 0.4× 47 0.6× 47 0.8× 21 358
Lara del Campo Spain 12 196 1.6× 80 0.7× 16 0.2× 89 1.2× 126 2.2× 21 433
Richard W. Gurich United States 8 117 1.0× 38 0.4× 39 0.5× 14 0.2× 41 0.7× 14 243

Countries citing papers authored by Gilli Erez

Since Specialization
Citations

This map shows the geographic impact of Gilli Erez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gilli Erez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gilli Erez more than expected).

Fields of papers citing papers by Gilli Erez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gilli Erez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gilli Erez. The network helps show where Gilli Erez may publish in the future.

Co-authorship network of co-authors of Gilli Erez

This figure shows the co-authorship network connecting the top 25 collaborators of Gilli Erez. A scholar is included among the top collaborators of Gilli Erez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gilli Erez. Gilli Erez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Erez, Gilli, Lucy Selman, & Fliss EM Murtagh. (2016). Measuring health-related quality of life in patients with conservatively managed stage 5 chronic kidney disease: limitations of the Medical Outcomes Study Short Form 36: SF-36. Quality of Life Research. 25(11). 2799–2809. 42 indexed citations
2.
Erez, Gilli, Amir Tirosh, Assaf Rudich, et al.. (2010). Phenotypic and genetic variation in leptin as determinants of weight regain. International Journal of Obesity. 35(6). 785–792. 42 indexed citations
3.
Durst, Ronen, Yehuda Neumark, Vardiella Meiner, et al.. (2009). Increased Risk for Atherosclerosis of Various Macrophage Scavenger Receptor 1 Alleles. Genetic Testing and Molecular Biomarkers. 13(5). 583–587. 11 indexed citations
4.
Zeharia, Avraham, Avraham Shaag, Riekelt H. Houtkooper, et al.. (2009). Mutations in LPIN1 Cause Recurrent Acute Myoglobinuria in Childhood. The American Journal of Human Genetics. 84(1). 95–95. 2 indexed citations
5.
Zeharia, Avraham, Avraham Shaag, Riekelt H. Houtkooper, et al.. (2008). Mutations in LPIN1 Cause Recurrent Acute Myoglobinuria in Childhood. The American Journal of Human Genetics. 83(4). 489–494. 163 indexed citations
6.
Friedlander, Yechiel, Stephen M. Schwartz, Ronen Durst, et al.. (2007). SREBP-2 and SCAP isoforms and risk of early onset myocardial infarction. Atherosclerosis. 196(2). 896–904. 20 indexed citations
7.
Szalat, Auryan, Gilli Erez, & Eran Leitersdorf. (2007). Aspirin withdrawal prior to invasive medical procedures: a strategy based on thromboembolic and bleeding risk stratification.. PubMed. 9(6). 435–8. 4 indexed citations
8.
Erez, Gilli & Eran Leitersdorf. (2006). The Rationale for Using HMG-CoA Reductase Inhibitors (‘Statins’) in Peripheral Arterial Disease. European Journal of Vascular and Endovascular Surgery. 33(2). 192–201. 14 indexed citations
9.
Durst, Ronen, Angelique C.M. Jansen, Gilli Erez, et al.. (2006). The discrete and combined effect of SREBP-2 and SCAP isoforms in the control of plasma lipids among familial hypercholesterolaemia patients. Atherosclerosis. 189(2). 443–450. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026